title: Acute liver failure in a pediatric patient with disseminated tuberculosis.
authors.affiliation: Stanford University School of Medicine, Stanford, CA 94305, USA. jane.whitney@stanford.edu
authors.forename: Jane
authors.initials: J
authors.lastname: Whitney
authors.forename: Melissa
authors.initials: M
authors.lastname: Hurwitz
authors.forename: Amirkaveh
authors.initials: A
authors.lastname: Mojtahed
authors.forename: Christine
authors.initials: C
authors.lastname: Hwang
authors.forename: Amy
authors.initials: A
authors.lastname: Gallo
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D003047:Coccidioidomycosis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use; D017114:Liver Failure, Acute / Q000139:chemically induced* / Q000175:diagnosis* / Q000503:physiopathology; D008297:Male; D011718:Pyrazinamide / Q000009:adverse effects / Q000627:therapeutic use; D020127:Recovery of Function / Q000502:physiology; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents; D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D015725:Fluconazole; D007538:Isoniazid; D012293:Rifampin